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The catP gene has been found on various
bacterial chromosomes and conjugative plas-
mids as part of the transposable element
Tn4451. This transposon is derivative of the
Tn6338 that contains six genes, the largest of
which, TnpX, is required for the excision of the
transposon in both Escherichia coli and
C. perfringens (6). The Tn4451 derivative that
lacked the functional TnpX gene was com-
pletely stable in both organisms because it had
lost mobility as a result of these internal
deletions (6). The finding of catP in
N. meningitidis within such a truncated
immobile transposon (1) and the possibility of
transfer of this type of resistance among highly
transformable organisms such as Neisseria spp.
are of great concern. Were the transposon to
become a stable part of the meningococcal
genome, it could potentially be easily ex-
changed. Interspecies recombination between
antibiotic-resistant genes of N. meningitidis
and commensal Neisseria spp. has occurred in
penicillin- and sulfonamide-resistant meningo-
cocci (7-10). A similar occurrence may be
possible for N. meningitidis chloramphenicol
resistance in Africa or other continents where
this antibiotic is routinely used for treatment of
patients with meningococcal diseases. Studies
have not yet demonstrated the clinical signifi-
cance of chloramphenicol resistance caused by
the catP gene in meningococci. However, it is
possible that, in developing countries, patients
whose illness does not respond to antimicrobial
agents may not be detected, or their isolates
may not be obtained. Screening a selection of
isolates for catP may allow early detection of
chloramphenicol-resistant strains. Since detec-
tion of increasing chloramphenicol resistance
could change recommendations for antimicro-
bial-drug therapy, surveillance for antimicro-
bial-drug resistance should be encouraged.
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Iron Loading and Disease Surveillance
To the Editor: We read with interest the article
by E. D. Weinberg entitled “Iron Loading and
Disease Surveillance” (1). Dr. Weinberg pro-
poses routine population screening of iron
values by serum ferritin and transferrin satura-
tion tests. Such screening could provide valu-
able information for epidemiologic, diagnostic,165 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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prophylactic, and therapeutic studies of emerg-
ing infectious diseases. However, population
screening for hereditary hemochromatosis, the
example Dr. Weinberg uses to illustrate his
proposal, should await additional data (2-4). At
this time, it is not known how many people with
genetic risk or biochemical evidence of iron
overload will actually become ill. Therefore, the
benefits of screening cannot be weighed against
the risks of unnecessary treatment. Moreover,
standardized, reliable methods for measuring
and diagnosing iron overload are not available.
Without additional data, population screen-
ing can actually be detrimental to those at risk
for disease. Persons with hereditary hemochro-
matosis may face discrimination, including
difficulties in acquiring health, life, or disability
insurance. Already, current blood safety policy
makes it difficult for them to donate blood, even
though blood donation is unlikely to have
negative consequences. In addition, the costs of
screening for hemochromatosis are not rou-
tinely covered by medical insurance nor has the
cost-effectiveness of screening been determined.
If routine screening is adopted, tracking of
persons who test positive must be developed to
ensure that appropriate and continuing follow-
up is provided and patient confidentiality is
preserved.
The Centers for Disease Control and Pre-
vention recommends testing for persons who
have either a close relative with hemochromato-
sis or who themselves experience the unex-
plained symptoms compatible with the disease
(severe weakness or fatigue; unexplained joint
or abdominal pain) or its later complications
(liver disease, diabetes, or heart problems;
impotence; infertility; loss of menstrual periods)
(2,5). Testing to exclude other causes of these
medical problems should also be performed.
Persons with elevated iron or liver function
measures should be monitored by their health-
care provider.
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Reply to Dr. Reyes
To the Editor: The article noted that nearly 50
microbial genera contain strains that are more
pathogenic in iron-loaded than in normal hosts.
The article proposed “routine screening of
populations exposed to certain diseases” but not
routine screening of populations at large. A few
examples of current interest include atheroscle-
rosis (Coxiella and Chlamydia), septicemia
(Capnocytophaga), Whipple’s disease
(Tropheryma), tuberculosis (Mycobacterium),
gastric ulcers (Helicobacter), hepatitis (hepatitis
C), and AIDS (opportunistic pathogens).
Of course, the tissue or cell localization of
iron and the possible pathogen must be consid-
ered. For instance, Legionella multiplies in
iron-loaded alveolar macrophages but not in
plasma.  Thus, it would be expected that per-
sons with untreated hemochromatosis with
minimal macrophage iron but with high plasma
iron would not be at risk for Legionnaires’
pneumonia.
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